Resources for Food and Drug Administration (FDA)

FDA Warns LabCorp About Illegal Sales Of Ovarian Cancer Test

www.medicalnewstoday.com

The US Food and Drug Administration (FDA) has written to global clinical network giant LabCorp to warn the company it is violating the law on a number of counts by selling its ovarian cancer test OvaSure. There was no suggestion that there was something clinically wrong with the test. n the letter the FDA warned David P King, LabCorp president and CEO, that his firm was in serious violation of the Food, Drug, and Cosmetic Act involving the illegal marketing of the OvaSure test. The agency said because LabCorp did not seek marketing clearance or approval from the FDA, marketing OvaSure was against the law.

View the Resource

Share or bookmarklet this web page at: